INVA logo

INVAInnoviva Inc

$22.52
$0.36
(1.63%)
Today
Closed $22.52
$0.0311
(0.14%)
After Hours
Updated: 05:49 PM EDT
EarningsAug 5
Mkt Cap$1.64B
Vol845,413.00
News
all
press releases
Innoviva to Participate in Upcoming Investor Conferences
Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets...
Business Wire
News Placeholder
More News
News Placeholder
Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More
Key PointsDauntless Investment Group bought 116,863 shares of Innoviva in an estimated trade of $2.52 million last quarter...
Nasdaq News: Markets
News Placeholder
Innoviva (INVA) Tops Q1 Earnings Estimates
Innoviva (INVA) delivered earnings and revenue surprises of +3.53% and -1.83%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress
Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as...
Business Wire
News Placeholder
Pfizer (PFE) Q1 Earnings and Revenues Top Estimates
Pfizer (PFE) delivered earnings and revenue surprises of +5.63% and +4.56%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Jennison Associates LLC Buys New Shares in Innoviva, Inc. $INVA
Jennison Associates LLC purchased a new position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 46,403 shares of the biotechnology company's stoc...
MarketBeat
News Placeholder
Merck (MRK) Reports Q1 Loss, Tops Revenue Estimates
Merck (MRK) delivered earnings and revenue surprises of +15.47% and +2.44%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Innoviva (INVA) to Release Quarterly Earnings on Wednesday
Innoviva (NASDAQ:INVA) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...
MarketBeat
News Placeholder
Innoviva, Inc. (NASDAQ:INVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Innoviva, Inc. (NASDAQ:INVA - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven brokerages that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and fiv...
MarketBeat
News Placeholder
Innoviva (NASDAQ:INVA) Shares Cross Above 200-Day Moving Average - Time to Sell?
Innoviva (NASDAQ:INVA) Shares Cross Above 200-Day Moving Average - Here's Why...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.